Matches in Wikidata for { <http://www.wikidata.org/entity/Q65352558> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q65352558 description "clinical trial" @default.
- Q65352558 description "ensayu clínicu" @default.
- Q65352558 description "klinisch onderzoek" @default.
- Q65352558 description "клінічне випробування" @default.
- Q65352558 description "կլինիկական փորձարկում" @default.
- Q65352558 name "Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer" @default.
- Q65352558 name "Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer" @default.
- Q65352558 type Item @default.
- Q65352558 label "Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer" @default.
- Q65352558 label "Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer" @default.
- Q65352558 prefLabel "Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer" @default.
- Q65352558 prefLabel "Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer" @default.
- Q65352558 P1132 Q65352558-9F751EB5-760A-47B4-A867-5907B3286CBF @default.
- Q65352558 P131 Q65352558-9F209FD7-A36C-47AC-BBF2-816CCBF749B4 @default.
- Q65352558 P1476 Q65352558-155BEC0E-745C-4C32-AB82-FE22A128C7D0 @default.
- Q65352558 P17 Q65352558-0EEBD3D9-0173-48F7-A4FC-7198D52415C0 @default.
- Q65352558 P17 Q65352558-1939CBAD-D824-46BA-B866-1C03B77832AD @default.
- Q65352558 P17 Q65352558-5EBA5AA6-119F-4940-8F08-AA782CB242BA @default.
- Q65352558 P17 Q65352558-69D76746-0A85-471F-BF1C-407E282EA918 @default.
- Q65352558 P17 Q65352558-79D87146-ADB3-42D4-A26B-F06793057E47 @default.
- Q65352558 P17 Q65352558-82DCF6AD-9999-4F3F-A330-C4BE88770E37 @default.
- Q65352558 P17 Q65352558-DDDB4216-3427-4972-84B1-A29D35EA3B17 @default.
- Q65352558 P17 Q65352558-ED187A9D-3356-425B-9E27-9980067DFF35 @default.
- Q65352558 P17 Q65352558-ED898135-A581-40F5-9758-6B0F7084955F @default.
- Q65352558 P17 Q65352558-F066E331-9D50-4AE0-BC07-F7679E241D08 @default.
- Q65352558 P2899 Q65352558-72B0087C-E6D0-401A-BCCF-EB427331FEA9 @default.
- Q65352558 P3098 Q65352558-1F03D7BD-2C57-4B68-B0AA-187AA7B870ED @default.
- Q65352558 P31 Q65352558-F1E53611-8E4E-4CC3-9D78-B32BB2B9B57F @default.
- Q65352558 P580 Q65352558-F344713C-CA0A-4F75-BAC9-5E9BA6C9352E @default.
- Q65352558 P582 Q65352558-6CFF50FB-DA5A-437B-B087-B76E353EA144 @default.
- Q65352558 P6099 Q65352558-EBF56050-7E43-4696-B36C-7FA0CEFA407C @default.
- Q65352558 P6153 Q65352558-76F7F7E4-E832-4ACF-9F6D-8010D6CE39A9 @default.
- Q65352558 P8363 Q65352558-4A6398E9-93D0-4F06-B6DD-170A81A71054 @default.
- Q65352558 P859 Q65352558-D862FA88-F27B-442C-94F7-F7F852036DDE @default.
- Q65352558 P1132 "+225" @default.
- Q65352558 P131 Q8646 @default.
- Q65352558 P1476 "An Open-Label, Phase II, Study to Evaluate Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer Receiving Treatment With Trastuzumab in Combination With Lapatinib or Chemotherapy (EGF117165)" @default.
- Q65352558 P17 Q155 @default.
- Q65352558 P17 Q29 @default.
- Q65352558 P17 Q30 @default.
- Q65352558 P17 Q38 @default.
- Q65352558 P17 Q40 @default.
- Q65352558 P17 Q414 @default.
- Q65352558 P17 Q419 @default.
- Q65352558 P17 Q869 @default.
- Q65352558 P17 Q928 @default.
- Q65352558 P17 Q96 @default.
- Q65352558 P2899 "+18" @default.
- Q65352558 P3098 "NCT02213042" @default.
- Q65352558 P31 Q30612 @default.
- Q65352558 P580 "2014-10-24T00:00:00Z" @default.
- Q65352558 P582 "2019-08-05T00:00:00Z" @default.
- Q65352558 P6099 Q42824440 @default.
- Q65352558 P6153 Q507154 @default.
- Q65352558 P8363 Q78089383 @default.
- Q65352558 P859 Q507154 @default.